Questions about a clinical trial?

If you are a patient or a health care provider and would like more information about a clinical trial, please contact our research team.

Search Clinical Trials

  • Age
  • Available Documents
  • Patient Level Data Anonymized patient level data for select studies available to qualified scientific researchers
  • Phases <strong>Phase 1:</strong> A step in clinical research to focus on the safety of a drug and how it works in the body.

<strong>Phase 2:</strong> A step in clinical research to gather data on whether a drug works in people who have a certain condition or disease.

<strong>Phase 3:</strong> A step in clinical research that gathers more information about a drug’s safety and if it works in people.

<strong>Phase 4:</strong> A step in clinical research after regulatory authorities have approved a drug for marketing.

<strong>N/A:</strong> For observational studies or interventional studies that do not support drug development.
  • Results
  • Sex In this context, a person’s sex refers to that person’s assigned sex at birth. This has been the case historically; however, there is growing understanding in the healthcare community that this definition excludes certain segments of the population and should be expanded, where possible, to account for gender identity as well. BeiGene recognizes the importance of making clinical trials accessible to all groups of people and is committed to promoting inclusive research.
  • Study Status <strong>Recruiting:</strong> The study is open to enrollment for qualified participants.

<strong>Will be Recruiting:</strong> The study has not yet opened enrollment for qualified participants.

<strong>Recruitment Complete:</strong> The study is ongoing, and participants are receiving an intervention or being examined, but new potential participants are not currently being recruited or enrolled.

<strong>Completed:</strong> The study has ended normally, and participants are no longer receiving an intervention or being examined.

<strong>Other:</strong> All other study statuses such as withdrawn, canceled, or terminated.
  • Study Type <strong>Expanded Access:</strong> A way for patients with serious diseases or conditions who cannot participate in a clinical study to gain access to a medical product that has not been approved by regulatory authorities. Also called compassionate use.

<strong>Interventional:</strong> A type of clinical trial in which participants are assigned to groups that receive one or more treatment or study drug (intervention).

<strong>Observational:</strong> A type of clinical study in which participants may receive diagnostic or study drugs but the study investigator does not assign participants to a a specific intervention or treatment.
  • Vaccine Studies
Clear

Search Results

Study ID
Phase
Condition(s)
Status
Sex
Age Range

BGB-3111-217

2

Lupus Nephritis

Recruiting

All

18 Years to 70 Years   (Adult, Older Adult)

Learn More

BGB-3111-217

Recruiting

Phase

2

Condition

Lupus Nephritis

Sex

All

Age

18 Years to 70 Years   (Adult, Older Adult)


BGB-A317-314

3

Classical Hodgkin Lymphoma

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-314

Recruiting

Phase

3

Condition

Classical Hodgkin Lymphoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-3111-110

1

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-3111-110

Recruiting

Phase

1

Condition

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-A317-211

2

Hepatocellular Carcinoma | Unresectable Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

Recruiting

All

18 Years to 70 Years   (Adult, Older Adult)

Learn More

BGB-A317-211

Recruiting

Phase

2

Condition

Hepatocellular Carcinoma | Unresectable Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma

Sex

All

Age

18 Years to 70 Years   (Adult, Older Adult)


BGB-A317-315

3

Non Small Cell Lung Cancer

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-315

Recruiting

Phase

3

Condition

Non Small Cell Lung Cancer

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-A317-210

2

Classical Hodgkin Lymphoma

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-210

Recruiting

Phase

2

Condition

Classical Hodgkin Lymphoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-A317-3111-10188-101

1/2

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Follicular Lymphoma | Marginal Zone Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Advanced Solid Tumor | Non-small Cell Lung Cancer | Metastatic Melanoma

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-3111-10188-101

Recruiting

Phase

1/2

Condition

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Follicular Lymphoma | Marginal Zone Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Advanced Solid Tumor | Non-small Cell Lung Cancer | Metastatic Melanoma

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-11417-101

1

Mature B-Cell Malignancies

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-11417-101

Recruiting

Phase

1

Condition

Mature B-Cell Malignancies

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-A317-A445-101

1

Advanced Solid Tumor

Recruiting

All

18 Years and older   (Adult, Older Adult)

Learn More

BGB-A317-A445-101

Recruiting

Phase

1

Condition

Advanced Solid Tumor

Sex

All

Age

18 Years and older   (Adult, Older Adult)


BGB-3111-111 JapicCTI-195047

1/2

Mature B-cell Malignancies

Recruiting

All

20 Years and older   (Adult, Older Adult)

Learn More

BGB-3111-111 JapicCTI-195047

Recruiting

Phase

1/2

Condition

Mature B-cell Malignancies

Sex

All

Age

20 Years and older   (Adult, Older Adult)